Related Experiment Videos
Serum prostatic acid phosphatase, gamma-seminoprotein and prostatic specific antigen in hemodialysis patients
I Sasagawa1, T Nakada, T Hashimoto
1Department of Urology, Yamagata University, School of Medicine, Japan.
Urologia Internationalis
|January 1, 1992
Abstract:
Serum concentrations of prostatic acid phosphatase (PAP), gamma-seminoprotein (gamma-Sm) and prostatic specific antigen (PSA) were measured in 31 hemodialysis patients without clinical signs of malignant disease. PAP, gamma-Sm and PSA levels in serum were not significantly different between control and hemodialysis groups. A significant reduction in these tumor markers was not found after dialysis treatment. This indicates that the measurement of PAP, gamma-Sm and PSA in serum is useful for the detection of prostatic cancer in patients undergoing hemodialysis.